In an interview published in the Catalan newspaper “La vanguardia”, Carlos Lurigados and Ángel Chamorro, CEO and Scientific Advisor of FreeOx Biotech respectively, talk about the creation of the company in 2007 as a spinout of the Hospital Clínic, of the recent addition to the team of DDR and AEC partners to complement both the regulatory and strategic aspects, and the launch of an investment round of 1 million euros, of which 40% have already been collected.
Click here to access the interview (in Spanish)
